1Joseph Oyepata Simeon, 2Joseph Opeyemi Tosin, 3Adeoye David Adegbenga
1,3Departmennt of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Federal University, Oye–Ekiti, Ekiti State, Nigeria
2Department of Pharmacy, University College Hospital, Ibadan, Oyo State, Nigeria
DOI : https://doi.org/10.47191/ijmra/v4-i12-20Google Scholar Download Pdf
ABSTRACT:
COVID -19 have affected over 200 million and killed about 5 million people globally. Many steps have been taken to understand its dynamics, etiology and infectivity. Several approach have also been taken to control and manage the virus, while vaccines have been developed to prevent the rate of infectivity. Because of complete lack of knowledge of the virus, shortage in vaccine supply etc, understanding how the virus spread per country may determine relativity in vaccine emergency. The aim of this study is to determine the relative global consequences of cumulative distribution of Covid-19, using the USA as comparism factor and cumulative covid -19 data of 31st October 2021. Data from one hundred and fifty four countries were selected based on their continents, countries and cases of infection. Data were obtained from United Nations Geoscheme and WHO. They were analyzed and compared to that of the United State of America (USA) value. Data analyzed showed that most Africa countries are least to be affected while Americans and Europeans appear to be most affected. Result from the study shows that Africa may have develop mechanisms to cope and survive the virus pandemic compared to other region of the world. Hence, vaccine priority may be considered base on infectivity and severity of infection.
KeywordsAfrica, USA, COVID-19, countries, continent
REFERENCES
1) Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. (April 2020). "Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review". The Cochrane Database of Systematic Reviews. 4: Page 25-32
2) COVID-19 vaccines". World Health Organization (WHO). Retrieved 3 March 2021.
3) COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) . ArcGIS. Johns Hopkins University. Retrieved 3 November 2021.
4) Page J, Hinshaw D, McKay B (26 February 2021). In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market – The man with the first confirmed infection of the new coronavirus told the WHO team that his parents had shopped there". The Wall Street Journal. Retrieved 27 February 2021.
5) Joseph O. S., Builders M., Joseph O. T., Sabastine A. Z. (2020). Assessing differential impacts of COVID-19 on African countries: A comparative study. International Journal of Research and Innovation in Applied Science. Vol. 5, Issue 5. Page 197-203
6) Joseph O S., Musa T L., Joseph O T. , Ibhafidon I. (2020). The Dynamics of Differential Impacts of COVID-19 on African Countries Compared to Other Parts of the World. International journal of multidisciplinary research and analysis. Volume 03 Issue 11. Page 185-198.
7) Joseph OS , Builders M , Joseph O T , Famojuro TI, Ogira JO, Moses FD, Musa TL. (2021). Effect of the Demographic of Covid-19 on Different Countries; Using the USA for Comparism. International journal of multidisciplinary research and analysis. Volume 04 Issue 02. Page 193-203.
8) Joseph O. S, Sabastine A. Z, Joseph O. T. (2021). Global Implication of Differential Impacts of Covid-19 on Different Countries Using the USA as A Comparism Factor. Journal of Nursing and Health Science. Volume 10, Issue 5. PP 36-44.
9) Zimmer C (26 February 2021). "The Secret Life of a Coronavirus – An oily, 100-nanometer-wide bubble of genes has killed more than two million people and reshaped the world. Scientists don't quite know what to make of it". Retrieved 28 February 2021.
10) Islam MA (April 2021). "Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients. PLOS ONE. 16 (4): Pg 224-234..
11) Joseph O. S, Sabastine A. Z, Joseph O. T. (2021). Clinical evaluation of the potential benefits of taking Moringa oleifera on blood triglyceride and cholesterol level in patient taking Tenofovir/Lamivudine/Efavirenz (TLE) combination. Journal of Pharmaceutical Science & Research. Vol. 13(10), 623-629.
12) Islam MA (November 2020). "Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients". Frontiers in Neurology. 11: 562634.
13) Saniasiaya J, Islam MA (April 2021). "Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients". The Laryngoscope. 131(4): 865–878.
14) Saniasiaya J, Islam MA (November 2020). "Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients". Otolaryngology–Head and Neck Surgery. 165 (1): 33–42.
15) Agyeman AA, Chin KL, Landersdorfer CB, Liew D, Ofori-Asenso R (August 2020). "Smell and Taste Dysfunction in Patients With COVID-19: A Systematic Review and Meta-analysis". Mayo Clin. Proc. 95 (8): 1621–1631.
16) Joseph O.S., Builders M., Emem E.U and Joseph O.T. (2019). effect of ethanol leaf extract of cassia angustifolia extract on liver of wister rats. Global Scientific Journal. Volume 8, Issue 9. Page 1112-11120.
17) Oran DP, Topol EJ (January 2021). "The Proportion of SARS-CoV-2 Infections That Are Asymptomatic : A Systematic Review". Annals of Internal Medicine. 174 (5): M20-6976.
18) Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease
(COVID-19) . U.S. Centers for Disease Control and Prevention (CDC). 6 April 2020. Archived from the original on 2 March 2020. Retrieved 19 April 2020.
19) CDC (2020). Post-COVID Conditions. Centers for Disease Control and Prevention. Retrieved 12 July 2021.
20) Wu X, Nethery RC, Sabath MB, Braun D, Dominici F (November 2020). "Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis". Science Advances. 6 (45): 342-355.
21) Joseph O.S, Builders M., Joseph O, T. , Zubairu S. A., Musa T. And Oyepata P. J (2019). Sub-Acute Toxicity Study of Ethanol Leaf Extract of Ocimum Canum on Liver of Wister Rats. International Journal of Research and Scientific Innovation. Volume VI (V). Pp. 364-369.
22) Oyebadejo S. A, Joseph O. S, Adesite S. O and Omorilewa A.O. (2019). Effect of Citrus Limon Juice and Tamoxifen on the Tumour growth mass Indices, Cell Proliferation, Cell Viability and Cytogenetic (Mitotic Index) of Sprague Dawley Rats Induced MCF-7 Breast Cancer Cells. Saudi Journal of Biomedical Research. (4). Pg. 216 - 225.
23) Modupe I. B., Oyepata S. J. and Akpobome R. V. (2019). Effect of Parkia biglobosa extract on open skin wound healing in dexamethasone - induced hyperglycaemia and histological assessment in rats. African Journal of Pharmacy and Pharmacology. Vol. 13(8), pp. 84-89.
24) Pansini R, Fornacca D (June 2021). Early Spread of COVID-19 in the Air-Polluted Regions of Eight Severely Affected Countries. Atmosphere. 12 (6): 795.
25) Comunian S, Dongo D, Milani C, Palestini P (June 2020). Air Pollution and Covid-19: The Role of Particulate Matter in the Spread and Increase of Covid-19's Morbidity and Mortality. International Journal of Environmental Research and Public Health. 17 (12): 4487.
26) Domingo JL, Marquès M, Rovira J (September 2020). "Influence of airborne transmission of SARS-CoV-2 on COVID-19 pandemic. A review". Environmental Research. 188: 66-73.
27) COVID-19: Who's at higher risk of serious symptoms? . Mayo Clinic.
28) Joseph O. S., Jude E.O and Joseph O. T (2018). Hepatoprotective activity of extract of Homalium Letestui stem against carbon tetrachloride-induced liver injury. Advance Herbal Medicine. Vol 4(4), Page 1-11.
29) Joseph O. S., Builders M., Joseph O. T., Zubairu S.A., Musa T. and Oyepata p.j. (2019). Sub-acute toxicity study of ethanol leaf extract of Ocimum canum on the kidney of wistar rats. African Journal of Pharmaceutical Research & Development. Vol. 11 No.1. Page 1-7.
30) Tamara A, Tahapary DL (July 2020). "Obesity as a predictor for a poor prognosis of COVID-19: A systematic review". Diabetes & Metabolic Syndrome. 14 (4): 655–659.
31) Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. (July 2020). Obesity – A risk factor for increased COVID-19, severity and lethality (Review) . Molecular Medicine Reports. 22 (1): 9–19.
32) Builders M., Joseph O. S., Timothy O. O., Philip B. (2020). Antimalarial Drugs and COVID -19. Sumerianz Journal of Medical and Healthcare. Vol. 3, No. 12, pp. 111-116.
33) Fan Y, Zhao K, Shi ZL, Zhou P. Bat Corona viruses in China. Viruses. 2019.11 (3): 210-223.
34) Jude E. O., Joseph O. S. and Emem E. U. (2016). Nephroprotective activity of Homalium letestui stem extract against paracetamol induced kidney injury. Journal of Experimental and Integrative Medicine. Volume 6 (1): 38-43.
35) Joseph O.S., Builders M., Emem E.U and Joseph O.T. (2019). effect of ethanol leaf extract of Cassia angustifolia extract on kidney of Wister Rats. Global Scientific Journal. Volume 8, Issue 9. Page 1023-1031.
36) Cherry, J, Demmler-Harrison GJ, Kaplan SL.; Steinbach WJ, Hotez PJ. Feign and Cherry's Textbook of Pediatric Infectious Diseases. Elsevier Health Sciences. 2017. p. 453-466.
37) Woo PC, Huang Y, Lau SK, Yuen KY. Corona virus genomics and bioinformatics analysis. Viruses. 2010. 2 (8): 1804–20.
38) Almeida JD, Berry DM, Cunningham CH, Hamre D, Hofstad MS, Mallucci L, McIntosh K, Tyrrell DA. Virology: Coronaviruses. Nature. 1968. 220 (5168): 265-278.
39) Jude E. O., Joseph O. S. and Emem E. U. (2016). Nephroprotective activity of Homalium letestui stem extract against paracetamol induced kidney injury. Journal of Experimental and Integrative Medicine. Volume 6 (1): 38-43.
40) https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant.html
41) Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet. 2020. 395 (10223): 507–513
VOLUME 04 ISSUE 12 December 2021
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 12 (December 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 December 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.